Calidi Biotherapeutics CLDI Income Statement (2021-2026)

NYSE CLDI
$1.32 -0.08 (-5.71%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating items
Research & Development (Quarter) 1.95M2.26M2.62M3.18M3.25M3.96M2.74M2.17M2.15M1.81M2.42M2.59M2.36M2.36M2.56M
Selling, General & Administrative (Quarter) 5.04M2.42M2.79M3.36M3.97M5.86M4.01M3.60M3.07M2.21M2.64M3.07M2.69M2.11M1.59M
Other Operating Expenses (Quarter) 0.53M0.36M9.14M
Operating Expenses (Quarter) 0.53M0.36M6.99M4.69M5.41M6.54M7.22M9.82M6.75M5.77M5.23M4.03M5.06M5.66M5.05M4.47M4.15M
Operating Income (Quarter) -0.53M-0.36M-6.99M-4.69M-5.41M-6.54M-7.22M-9.82M-6.75M-5.77M-5.23M-4.03M-5.06M-5.66M-5.05M-4.47M-4.15M
EBIT (Quarter) -0.53M-0.36M-6.99M-4.69M-5.41M-6.54M-7.22M-9.82M-6.75M-5.77M-5.23M-4.03M-5.06M-5.66M-5.05M-4.47M-4.15M
Non-operating items
Non Operating Investment Income (Quarter) 0.00M0.03M0.01M
Interest & Investment Income (Quarter) 0.02M0.16M1.09M
Other Non Operating Income (Quarter) 0.00M-0.01M-0.01M-0.02M-0.01M-0.02M-0.02M0.01M0.01M0.01M-0.01M-0.02M0.02M0.14M0.03M
Non Operating Income (Quarter) 1.99M4.52M1.63M-3.07M-1.04M-5.96M5.21M1.59M-0.47M0.01M0.16M-0.12M0.00M-0.09M-0.12M0.41M-0.01M
Net income details
EBT (Quarter) 1.46M4.16M-5.35M-7.76M-6.46M-12.50M-2.01M-8.23M-7.22M-5.76M-5.07M-4.14M-5.06M-5.76M-5.17M-4.06M-4.16M
Tax Provisions (Quarter) 0.00M-0.00M0.00M0.00M0.01M-0.00M0.00M0.01M-0.00M0.00M0.00M0.00M0.01M-0.02M0.01M
Profit After Tax (Quarter) -7.74M-4.58M-5.36M-7.76M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.07M-4.15M-5.06M-5.76M-5.18M-3.90M-4.16M
Income from Non-Controlling Interests (Quarter) -0.01M-0.05M-0.08M-0.05M-0.03M-0.00M
Income from Continuing Operations (Quarter) 1.46M4.16M-5.36M-7.76M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.07M-4.15M-5.06M-5.76M-5.18M-4.04M-4.16M
Consolidated Net Income (Quarter) 1.46M4.16M-5.36M-7.76M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.07M-4.15M-5.06M-5.76M-5.18M-4.04M-4.16M
Income towards Parent Company (Quarter) 1.46M4.16M-5.36M-7.76M-6.46M-12.50M-2.02M-8.23M-7.22M-5.77M-5.07M-4.15M-5.06M-5.76M-5.18M-4.04M-4.16M
Net Income towards Common Stockholders (Quarter) 1.46M4.16M-5.36M-7.76M-6.46M-12.50M-2.02M-8.23M-7.22M-7.44M-5.05M-4.10M-4.99M-5.71M-10.82M-4.06M-4.16M
Additional items
EPS (Basic) (Quarter) 7.6321.71-30.98-52.66-134.86-260.90-16.97-58.48-24.39-16.75-7.75-6.14-0.00M-0.00M-0.00M-942.82-2.94
EPS (Diluted) (Quarter) 7.6321.71-30.98-52.66-134.86-260.90-16.97-58.48-24.39-16.75-7.75-6.14-0.00M-0.00M-0.00M-942.82-2.94
Shares Outstanding (Quarter) 0.07M0.19M0.19M0.17M0.15M0.05M0.05M0.12M0.14M0.30M0.44M0.65M0.67M0.00M0.00M0.00M0.00M1.42M
Shares Outstanding (Diluted) (Quarter) 0.07M0.19M0.19M0.17M0.15M0.05M0.05M0.12M0.14M0.30M0.44M0.65M0.67M0.00M0.00M0.00M0.00M1.42M
Shares Outstanding (Entity) (Quarter) 0.07M0.19M0.19M0.17M0.15M0.05M0.05M0.12M0.14M0.30M0.44M0.78M0.67M0.00M0.00M0.00M0.00M1.42M
EBITDA (Quarter) -0.53M-0.36M-6.99M-4.69M-5.41M-6.54M-7.22M-9.82M-6.75M-5.77M-5.23M-4.03M-5.06M-5.66M-5.05M-4.47M-4.15M
Interest Expenses (Quarter) 0.46M0.03M0.76M0.34M0.30M4.64M-0.58M4.53M0.60M0.50M0.36M0.64M20.00M0.18M-48.53M1.06M
Tax Rate (Quarter) -0.02%0.04%-0.06%-0.03%-0.55%0.04%-0.06%-0.14%0.02%-0.07%-0.06%-0.07%-0.19%0.39%-0.12%